Who is affected by this change?

This affects Independence Blue Cross ENT (Ear, Nose & Throat) providers on Commercial plans.

When does this change take effect?

This change is effective Jul 1, 2025.

Back to dashboard

CommercialCoverageLow impact

11.01.06j, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids

Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy

Effective date

Jul 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a commercial policy update for bone-anchored hearing aids and implantable middle ear hearing aids, effective July 1, 2025. The policy appears to be a routine update to existing coverage guidelines for these specialized hearing devices.

Action Required

Action needed

By July 1, 2025: Billing team should review the full policy details at the source URL to understand any changes to coverage criteria for bone-anchored hearing aids and implantable middle ear hearing devices. Verify current billing procedures align with updated policy requirements.

Related policy hubs

Independence Blue Cross policies ENT (Ear, Nose & Throat)